Purchases and Sales Made in Q2 2020 in Salarius Pharmaceuticals, Inc. (SLRX)
This table provides information about the institutional ownership of Salarius Pharmaceuticals, Inc. (SLRX) during Q2 2020. The information is specifically focused on institutions that hold shares of Salarius Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 19, 2020
Q2 2020
|
Rmr Wealth Builders
|
BUY
|
- |
3KNew |
$1.8K - $5.46K
|
3K
$2.04K
|
|
Aug 14, 2020
Q2 2020
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
1.4K+ 12.31% |
$841 - $2.55K
|
12.8K
$8.7K
|
|
Aug 13, 2020
Q2 2020
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1+ 1.3% |
$0.6 - $1.82
|
78
$53
|
|
Aug 13, 2020
Q2 2020
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 14, 2020
Q2 2020
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-756- 44.37% |
$454 - $1.38K
|
948
$645
|
|
Aug 07, 2020
Q2 2020
|
Victory Capital Management Inc
|
SELL
|
- |
-1.97KClosed |
$1.18K - $3.59K
|
0
$0
|
|
Aug 12, 2020
Q2 2020
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-8.56KClosed |
$5.14K - $15.6K
|
0
$0
|
|
Jul 31, 2020
Q2 2020
|
Ubs Group Ag
|
SELL
|
- |
-11.1KClosed |
$6.67K - $20.2K
|
0
$0
|
|
Aug 13, 2020
Q2 2020
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-13.5K- 89.23% |
$8.1K - $24.6K
|
1.63K
$1.11K
|
|
Aug 14, 2020
Q2 2020
|
Worth Venture Partners, LLC
Fort Lee, NJ |
SELL
|
- |
-46.1K- 15.15% |
$27.7K - $83.9K
|
258K
$176K
|
|
Aug 13, 2020
Q2 2020
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-228KClosed |
$137K - $416K
|
0
$0
|